JILIN LONGKANG PHARMACEUTICAL CO.,LTD

JILIN LONGKANG PHARMACEUTICAL CO., LTD Jilin Longkang Pharmaceutical Co., Ltd is a manufacturer of traditional Chinese herbal materials and health products based in Jilin Province, China. The company was established in 2004 and operates with a workforce of 51 to 100 employees. PRODUCT FOCUS The company specializes in the production and supply of Rhizoma Atractylodis Japonicae (a traditional Chinese medicinal herb) alongside a broader range of herbal materials used in traditional Chinese medicine formulations. Their product portfolio includes medicinal tea blends and health products derived from botanical sources. The company positions itself within the traditional Chinese medicine (TCM) and herbal supplement manufacturing sector. OPERATIONAL SCALE With approximately two decades of operational history since its 2004 founding, Jilin Longkang operates at a mid-sized manufacturing scale. The employee range of 51-100 staff suggests capacity for local and regional distribution, though Reevol has not verified the company's current production volumes or manufacturing capacity specifications. MARKET PRESENCE AND CREDIBILITY SIGNALS The company maintains a website at http://www.jllongkang.com. However, Reevol has not verified details regarding certifications, regulatory approvals, quality standards, or third-party validations that would typically support buyer confidence in pharmaceutical and health product suppliers. Information regarding international certifications, GMP (Good Manufacturing Practice) compliance, or other industry-standard credentials is not available in public sources reviewed. EXPORT AND TRADE ACTIVITY Reevol has not identified documented export markets or trade fair participation for this company. The absence of visible international trade data suggests the company may primarily serve domestic Chinese markets, though this has not been independently verified. Buyers seeking products for export or import should conduct direct outreach to confirm cross-border capability and regulatory compliance. VISIBILITY AND BUYER CONSIDERATIONS The company's visibility score is minimal, indicating limited public digital footprint or international trade documentation accessible through standard supply chain intelligence channels. This positioning is not uncommon among regional Chinese herbal material suppliers that operate primarily within domestic distribution networks. Buyers interested in sourcing from Jilin Longkang Pharmaceutical should verify product certifications, quality assurance documentation, regulatory compliance with their destination markets, and manufacturing standards through direct supplier engagement. Given the traditional Chinese medicine sector's regulatory complexity across different jurisdictions, pre-purchase due diligence on product claims, ingredient sourcing, and applicable certifications is recommended.